CNTNAP2 and neurodevelopmental disorder: Next, we have identified IGF1R, UBE3C, KMT2C, EPHB6, TRPV5, ESYT2, DPP6, PTPRN2, and CNTNAP2 reported to have de novo mutations in multiple (more than 2) independent cases with neurodevelopmental disorders, including ASD.